Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent patients aged 5 years and older.

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

Katalin Karikó, a Nobel Prize laureate, Penn professor, and renowned mRNA researcher from Abington, has been inducted into ...

Imagine a world where the fear of paralysis loomed over every childhood summer. The smell of chlorine at the public poo ...

A new framework bridges a gap in understanding RNA therapeutics by linking the structure of lipid nanoparticles to immune ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

The CDC is moving toward a risk-based strategy, allowing patient input as to the frequency of COVID-19 vaccine boosters.

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that adults over 65 and immunocompromised people get ...